Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial.
Heinz-Josef LenzAparna ParikhDavid R SpigelAllen L CohnTakayuki YoshinoMark KochenderferElena Elez FernandezSpencer H ShaoDustin DemingRegan HoldridgeTimothy LarsonEric X ChenAmit MahipalAntonio UcarDana CullenEdwina Baskin-BeyTong KangAmy B HammellJin YaoJosep TaberneroPublished in: Journal for immunotherapy of cancer (2024)
NCT03414983.